BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 37535107)

  • 1. Feasibility of acquisitions using total-body PET/CT with a half-dose [
    Chen Z; Wang Y; Yang X; Li L; Huo Y; Yu X; Xiao X; Zhang C; Chen Y; Zhao H; Zhou Y; Huang G; Liu J; Chen R
    Eur J Nucl Med Mol Imaging; 2023 Nov; 50(13):3961-3969. PubMed ID: 37535107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The feasibility of ultra-early and fast total‑body [
    Chen R; Yang X; Yu X; Zhou X; Ng YL; Chen Y; Li L; Zhou Y; Huang G; Liu J
    Eur J Nucl Med Mol Imaging; 2023 Feb; 50(3):661-666. PubMed ID: 36308535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the role of 18 F-fluorodeoxyglucose PET/computed tomography and 68 Ga-labeled FAP inhibitor-04 PET/CT in patients with malignant mesothelioma.
    Güzel Y; Kömek H; Can C; Kaplan İ; Kepenek F; Ebinç S; Büyükdeniz MP; Gündoğan C; Oruç Z
    Nucl Med Commun; 2023 Jul; 44(7):631-639. PubMed ID: 37114422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Feasibility of a deep learning algorithm to achieve the low-dose
    Liu L; Chen X; Wan L; Zhang N; Hu R; Li W; Liu S; Zhu Y; Pang H; Liang D; Chen Y; Hu Z
    Br J Radiol; 2023 Sep; 96(1149):20230038. PubMed ID: 37393527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Usefulness of [
    Li C; Tian Y; Chen J; Jiang Y; Xue Z; Xing D; Wen B; He Y
    Eur Radiol; 2023 Apr; 33(4):2779-2791. PubMed ID: 36394603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The potential utility of [
    Lan L; Liu H; Wang Y; Deng J; Peng D; Feng Y; Wang L; Chen Y; Qiu L
    Eur J Nucl Med Mol Imaging; 2022 Feb; 49(3):963-979. PubMed ID: 34410435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of pediatric malignancies using total-body PET/CT with half-dose [
    Chen W; Liu L; Li Y; Li S; Li Z; Zhang W; Zhang X; Wu R; Hu D; Sun H; Zhou Y; Fan W; Zhao Y; Zhang Y; Hu Y
    Eur J Nucl Med Mol Imaging; 2022 Oct; 49(12):4145-4155. PubMed ID: 35788704
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Chen L; Zheng S; Chen L; Xu S; Wu K; Kong L; Xue J; Chen X; Miao W; Zhu Y
    J Nucl Med; 2023 Dec; 64(12):1899-1905. PubMed ID: 37918866
    [No Abstract]   [Full Text] [Related]  

  • 9. [
    Hu K; Wang L; Wu H; Huang S; Tian Y; Wang Q; Xiao C; Han Y; Tang G
    Eur J Nucl Med Mol Imaging; 2022 Jul; 49(8):2833-2843. PubMed ID: 34893920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of [
    Civan C; Kuyumcu S; Has Simsek D; Sanli O; Isik EG; Ozkan ZG; Hurdogan O; Sanli Y
    Eur J Nucl Med Mol Imaging; 2024 Feb; 51(3):852-861. PubMed ID: 37803246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Evaluation of
    Zhao L; Wen X; Xu W; Pang Y; Sun L; Wu X; Xu P; Zhang J; Guo Z; Lin Q; Chen X; Chen H
    J Nucl Med; 2023 Aug; 64(8):1210-1217. PubMed ID: 37142301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of early and late
    Hoppner J; van Genabith L; Hielscher T; Heger U; Sperling L; Colbatzky T; Gutjahr E; Lang M; Pausch T; Spektor AM; Glatting FM; Liermann J; Hackert T; Kratochwil C; Giesel FL; Haberkorn U; Röhrich M
    Sci Rep; 2023 Oct; 13(1):17848. PubMed ID: 37857656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The earliest optimal timing for total-body
    Zheng Z; Gao H; Lin Y; Yu H; Mao W; Yang R; He Y; Chen X; Wu H; Hu P; Shi H
    Eur Radiol; 2023 Dec; ():. PubMed ID: 38110627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PET Imaging of Fibroblast Activation Protein in Various Types of Cancer Using
    Pang Y; Zhao L; Meng T; Xu W; Lin Q; Wu H; Zhang J; Chen X; Sun L; Chen H
    J Nucl Med; 2023 Mar; 64(3):386-394. PubMed ID: 36215571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Feasibility of [
    Unterrainer LM; Lindner S; Eismann L; Casuscelli J; Gildehaus FJ; Bui VN; Albert NL; Holzgreve A; Beyer L; Todica A; Brendel M; Cyran CC; Karl A; Stief CG; Ledderose ST; Unterrainer M; Bartenstein P; Wenter V; Kretschmer A
    Eur J Nucl Med Mol Imaging; 2022 Aug; 49(10):3571-3580. PubMed ID: 35325283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Q.Clear reconstruction for reducing the scanning time for
    Ruan W; Qin C; Liu F; Pi R; Gai Y; Liu Q; Lan X
    Eur J Nucl Med Mol Imaging; 2023 Jun; 50(7):1851-1860. PubMed ID: 36847826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Head-to-Head Comparison of [
    Ballal S; Yadav MP; Roesch F; Raju S; Satapathy S; Sheokand P; Moon ES; Martin M; Awarwal S; Tripathi M; Bal C
    Thyroid; 2023 Aug; 33(8):974-982. PubMed ID: 37171126
    [No Abstract]   [Full Text] [Related]  

  • 19. Head-to-head intra-individual comparison of biodistribution and tumor uptake of
    Giesel FL; Kratochwil C; Schlittenhardt J; Dendl K; Eiber M; Staudinger F; Kessler L; Fendler WP; Lindner T; Koerber SA; Cardinale J; Sennung D; Roehrich M; Debus J; Sathekge M; Haberkorn U; Calais J; Serfling S; Buck AL
    Eur J Nucl Med Mol Imaging; 2021 Dec; 48(13):4377-4385. PubMed ID: 34137945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. One-stop [
    Liu G; Mao W; Yu H; Hu Y; Gu J; Shi H
    Eur J Nucl Med Mol Imaging; 2023 Jul; 50(8):2271-2281. PubMed ID: 36971806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.